# Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony

> **NCT07217899** · PHASE2 · RECRUITING · sponsor: **University of Michigan** · enrollment: 140 (estimated)

## Conditions studied

- Blood Loss, Surgical
- Blood Loss, Postoperative
- Uterine Atony

## Interventions

- **DRUG:** Calcium Gluconate
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT07217899
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-20
- **Primary completion:** 2026-07
- **Final completion:** 2026-08
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2025-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07217899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07217899, "Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07217899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*